DRUGS related term(s) Crime

Appointments

U.S. Senate Caucus on International Narcotices Council, S9690 [22SE]

U.S. Senate Caucus on International Narcotics Control, S1232 [30JA], S3092 [12MR], S9275 [10SE]

Articles and editorials

Acorn Amendment for Pfizer, H10489 [6OC]

Ambushed by a Drug War, S8075 [24JY]

Costly New Drugs—A Crisis for One Family, a Quandry for U.S., E2842 [1DE]

E. Coli Path Shows Flaws in Beef Inspection, H10535 [7OC]

Enemy Within, S8076 [24JY]

Medicare Part D `Reforms' Will Harm Seniors, S12469 [5DE]

Pentagon To Offer Swine Flu Vaccine to Terror Suspects, H12122 [29OC]

PHRMA Defends Vulnerable Dems, S6233 [8JN]

Ruin Your Health With the Obama Stimulus Plan, H1137 [10FE]

12 Federal Agents Are Slain in Mexico, S8078 [24JY]

White House & Big Pharma—What's the Deal?, S12507 [5DE]

White House Affirms Deal on Drug Cost, S10184 [7OC], S12753 [9DE]

Bills and resolutions

American Pharmacy Educator Week: designate (see H. Res. 857), H11712 [22OC]

Andean Trade Promotion and Drug Eradication Act: add Paraguay and Uruguay as beneficiary countries (see S. 1665), S9326 [14SE]

———add Paraguay as a beneficiary country (see S. 780), S4172 [1AP] (see H.R. 1837), H4395 [1AP]

Arizona: designate certain counties as high-intensity drug trafficking areas (see H.R. 1871), H4518 [2AP]

Armed Forces: improve and enhance substance use disorder programs for members (see S. 459), S2423 [24FE] (see H.R. 3420), H9205 [30JY]

———provide coverage under the Traumatic Servicemembers' Group Life Insurance for adverse reactions to vaccinations administered by the Dept. of Defense (see S. 1467), S7639 [16JY]

ATF: authorize additional resources to identify and eliminate illicit sources of firearms smuggled into Mexico for use by drug traffickers (see S. 205), S308 [12JA] (see H.R. 495), H323 [14JA] (see H.R. 1448), H3337 [11MR]

Children and youth: improve mental health and substance abuse services for juveniles by establishing new grant programs for increased training, technical assistance, and coordination of service providers (see H.R. 1931), H4521 [2AP]

Cocaine: adjust penalties for powder cocaine and crack cocaine offenses (see S. 1789), S10486 [15OC]

Colombia: recognize as an ally in the fight against extremism and drug trafficking and the benefits of passing a U.S.-Colombia Trade Promotion Agreement (see H. Res. 937), H13354 [19NO]

Controlled Substances Act: address use of intrathecal pumps (see H.R. 3018), H7249 [24JN]

———exclude industrial hemp from the definition of marijuana (see H.R. 1866), H4518 [2AP]

———prevent abuse of dextromethorphan (see S. 1383), S7070 [25JN]

Courts: clarify circumstances under which the enhanced penalty provisions for subsequent convictions apply (see H.R. 2933), H7021 [18JN]

Crime: address sentencing disparity between crack and powder cocaine (see H.R. 18), H28 [6JA] (see H.R. 1459), H3399 [12MR] (see H.R. 2178), H4999 [29AP] (see H.R. 3245), H8302 [16JY]

———concentrate Federal resources aimed at the prosecution of drug offenses on major offenses (see H.R. 1466), H3399 [12MR]

———deploy Border Patrol agents and increase number of DEA and ATF agents along U.S. border to identify and eliminate illicit sources of firearms smuggled into Mexico for use by drug traffickers (see H.R. 1900), H4520 [2AP]

———enhance penalties for marketing controlled substances to minors (see S. 258), S598 [15JA] (see H.R. 3702), H10456 [1OC]

———increase penalties for drug trafficking offenses relative to distribution of heroin, marijuana, and methamphetamine and distribution to and use of children (see H.R. 2469), H5712 [18MY]

———reduce rate of occurrence of homicides and violent crimes in violent and drug crime zones (see H.R. 4231), H13628 (see H.R. 4231), H14371 [8DE]

———target cocaine kingpins and address sentencing disparity between crack and powder cocaine (see H.R. 265), H70 [7JA]

Cuba: facilitate export of U.S. agricultural products, remove impediments to export of medical devices and medicines, allow travel by U.S. citizens, and establish an agricultural export promotion program (see S. 1089), S5700 [20MY] (see H.R. 1531), H3437 [16MR]

Cures Acceleration Network: establish to accelerate research discoveries into life-saving therapies (see S. 914), S4807 [28AP]

DEA: enhance ability to combat methamphetamine (see S. 256), S598 [15JA] (see H.R. 2923), H6972 [17JN]

Death and dying: reduce deaths occurring from overdoses (see H.R. 2855), H6743 [12JN]

Dept. of Defense: establish a TRICARE mail-order pharmacy pilot program (see H.R. 806), H920 [3FE]

Dept. of HHS: carry out a demonstration program to test the feasibility of using elementary and secondary schools as influenza vaccination centers (see H.R. 2596), H6010 [21MY]

———conduct or support a comprehensive study comparing total health outcomes, including risk of autism, in vaccinated populations with such outcomes in unvaccinated populations (see H.R. 3069), H7703 [26JN]

———develop an antimicrobial resistance research strategic plan (see H.R. 2400), H5581 [13MY]

———ensure patient choice in pharmacies by regulating pharmacy benefit managers and improving access to prescription drugs for certain individuals (see H.R. 4199), H13519 [3DE]

———ensure that safety net family planning centers are eligible for assistance under the 340B Drug Pricing Program (see S. 310), S787 [22JA]

———establish an Agency for Vaccine Safety Evaluation (see H.R. 2618), H6011 [21MY]

———expand authority to impose debarments in order to ensure the integrity of drug, biological product, and device regulation (see H.R. 3932), H11867 [27OC]

———extend deadlines applicable to filing petitions for compensation under the National Vaccine Injury Compensation Program (see H.R. 4096), H13068 [17NO]

———improve mental health and substance abuse health care (see H.R. 2369), H5484 [12MY]

———improve residential treatment programs for pregnant and parenting women and programs to reduce substance abuse among nonviolent offenders (see H.R. 439), H161 [9JA]

———optimize delivery of critical care medicine and expand the critical care workforce (see S. 1020), S5371 [12MY]

———protect human subjects in research (see H.R. 1715), H4026 [25MR]

———provide authority to order a mandatory recall of any product that is regulated by the FDA (see H.R. 841), H921 [3FE]

———provide for public disclosure of charges for certain hospital and ambulatory surgical center services and drugs (see H.R. 2566), H6009 [21MY]

———revise and expand the 340B Drug Pricing Program to improve provision of discounts on drug purchases for certain safety net providers (see S. 1239), S6542 [11JN] (see H.R. 444), H162 [9JA]

———revise the National Vaccine Injury Compensation Program (see H.R. 2459), H5711 [18MY]

Dept. of Homeland Security: authorize additional resources to enhance security activities along the international border with Mexico (see H.R. 1867), H4518 [2AP]

Dept. of HUD: reauthorize the Public Housing Drug Elimination Program (see S. 1327), S6938 [23JN] (see H.R. 582), H381 [15JA]

Dept. of Justice: authorize a national program to reduce drug use, crime, and the costs of incarceration (see H.R. 4055), H12587 [6NO]

———establish the National Parents Corps Program (see H.R. 3075), H7703 [26JN]

Dept. of State: permit certain foreign government officers or employees to be eligible for the Dept. of State Rewards Program (see H.R. 57), H30 [6JA]

Dept. of Transportation: establish and maintain national clearinghouse for alcohol and controlled substances testing records of commercial motor vehicle operators (see S. 1113), S5700 [20MY]

Diseases: encourage continued investment to complete development of an HIV/AIDS vaccine (see H. Res. 906), H13001 [16NO]

———establish programs and activities to increase influenza vaccination rates through the provision of free vaccines (see S. 953), S5013 [1MY]

———increase immunization rates (see S. 1003), S5281 [7MY]

———require group and individual health insurance coverage and group health plans to cover oral cancer drugs on terms no less favorable than coverage provided for intravenously administered anticancer medications (see H.R. 2366), H5484 [12MY]

Drug abuse: establish a drug-free workplace information clearinghouse, support residential treatment programs for pregnant and parenting women, and improve prevention and treatment of methamphetamine addiction (see H.R. 2818), H6617 [11JN]

Drug Price Competition and Patent Term Restoration Act: anniversary (see S. Res. 287), S9840 [24SE]

Drug testing: prohibit the manufacture, marketing, sale, or shipment of products designed to assist in defrauding a drug test (see H.R. 858), H1041 [4FE]

EPA: convene a task force to develop recommendations on the proper disposal of unused pharmaceuticals (see H.R. 276), H70 [7JA]

Families and domestic relations: allow children in foster care to be placed with their parents in residential family treatment centers that provide safe environments for treating addiction and promoting healthy parenting (see S. 1286), S6804 [18JN]

FDA: define term ``first applicant'' for purposes of filing an abbreviated application for a new drug (see S. 1315), S6887 [22JN] (see H.R. 3777), H11166 [8OC]

———ensure safety and quality of medical products and enhance authorities (see S. 882), S4669 [23AP]

———establish a user fee for follow-up reinspections (see S. 1477), S7779 [21JY]

———establish recall authority for drugs and increase criminal penalties for sale or trade of knowingly adulterated or misbranded prescription drugs (see H.R. 2726), H6264 [4JN]

———establish standards for the inclusion of risks, benefits, and comparative clinical effectiveness information in drug and device labeling and advertising (see S. 1142), S5819 [21MY]

———improve safety of food, drugs, devices, and cosmetics in the global market (see H.R. 759), H778 [28JA]

———prohibit use of Federal funds to approve certain biologics license applications (see S. 613), S3163 [17MR]

Federal Food, Drug, and Cosmetic Act: amend relative to distribution of the drug dextromethorphan (see H.R. 1259), H2923 [3MR]

———increase penalties relative to counterfeit drugs (see H.R. 1450), H3338 [11MR]

———preserve effectiveness of medically important antibiotics used in treatment of human and animal diseases (see S. 619), S3163 [17MR] (see H.R. 1549), H3525 [17MR]

———prevent certain delays by pharmaceutical companies in allowing introduction of generic drugs (see S. 1778), S10434 [14OC]

———prohibit marketing of authorized generic drugs (see S. 501), S2558 [26FE] (see H.R. 573), H380 [15JA]

———reduce human exposure to mercury through vaccines (see H.R. 2617), H6011 [21MY]

Government: prohibit from awarding contracts, grants, or other agreements to, providing any other Federal funds to, or engaging in activities that promote certain companies convicted of felonies (see H.R. 3679), H10407 [30SE]

Health: apply antitrust laws to negotiations between groups of independent pharmacies and health plans and health insurance issuers in the same manner as collective bargaining by labor organizations (see H.R. 1204), H2835 [25FE]

———give critical access hospitals health information technology grant priority, expand drug pricing program participation, study Medicaid pharmacy dispensing fees, and continue State rural health offices funding (see S. 2838), S12413 [4DE]

———optimize delivery of critical medicine and expand the critical care workforce (see H.R. 1581), H3640 [18MR]

———permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests (see H.R. 3261), H8409 [20JY]

———prevent abuse of dehydroepiandrosterone (see S. 641), S3550 [19MR]

———prohibit Federal funding or other assistance for mandatory human papillomavirus (HPV) vaccination programs (see H.R. 3188), H8024 [13JY]

———provide coverage of hormone replacement therapy and alternative therapies for treatment of menopausal symptoms (see H.R. 584), H381 [15JA]

———provide for sex education and substance abuse treatment and prevention (see H.R. 1364), H3054 [5MR]

———provide for the licensure of biosimilar and interchangeable biological products (see S. 726), S3897 [26MR] (see H.R. 1427), H3337 [11MR] (see H.R. 1548), H3525 [17MR]

———reform medical malpractice and liability system, improve access to health care for rural and indigent patients, and enhance access to affordable prescription drugs (see H.R. 3483), H9277 [31JY]

———understand and comprehensively address oral health problems associated with methamphetamine use (see S. 450), S2322 [13FE] (see H.R. 1671), H3748 [23MR]

Health care professionals: provide grants or contracts to create prescription drug education and outreach academic detailing programs (see S. 767), S4172 [1AP] (see H.R. 1859), H4396 [1AP]

Higher Education Act: repeal provisions prohibiting persons convicted of drug offenses from receiving student financial assistance (see H.R. 3295), H8585 [22JY]

House Rules: continue application of certain procedures applicable to Medicare funding (see H.R. 2321), H5398 [7MY]

Insurance: improve prescription drug coverage under Medicare and private health insurance (see S. 1630), S8993 [6AU] (see H.R. 3799), H11297 [13OC]

———require comprehensive coverage for childhood immunizations (see H.R. 323), H89 [8JA]

Law enforcement: coordinate efforts to protect U.S. border cities and communities from drug trafficking, gunrunning, illegal alien smuggling, violence, and kidnapping along and across the border with Mexico (see H.R. 1437), H3337 [11MR]

———increase evidentiary standard required to convict a person for a drug offense and require screening of law enforcement officers or others acting under color of law participating in drug task forces (see H.R. 68), H30 [6JA]

———increase penalties for trafficking in high potency marijuana (see H.R. 2848), H6742 [12JN]

———secure smuggling routes on the U.S.-Mexico border and better prevent the smuggling of narcotics and weapons across the border (see H.R. 2083), H4732 [23AP]

Marijuana: allow for medicinal use in accordance with State laws (see H.R. 2835), H6618 [11JN]

———eliminate most Federal penalties for possession of marijuana for personal use (see H.R. 2943), H7022 [18JN]

———provide an affirmative defense for medical use in accordance with the laws of the States (see H.R. 3939), H11868 [27OC]

Medicaid: allow States to permit certain eligible individuals who have extremely high annual lifelong orphan drug costs to continue on Medicaid notwithstanding increased income (see H.R. 1441), H3337 [11MR]

———extend drug rebate program to enrollees of managed care organizations (see S. 547), S2909 [9MR] (see H.R. 904), H1044 [4FE]

———provide coverage of drugs prescribed for certain NIH research study child participants (see S. 406), S2079 [10FE] (see H.R. 1421), H3145 [10MR]

———remove exclusion from medical assistance of items and services for patients in mental institutions (see H.R. 619), H442 [21JA]

———require drug manufacturers to pay rebates to State prescription drug discount programs as a condition of participation in a rebate agreement for outpatient prescription drugs (see H.R. 1725), H4026 [25MR]

———restore and protect access to discount drug prices for university-based and safety-net clinics (see H.R. 398), H160 [9JA]

Medicare: apply exceptions process for tiered formulary drugs to specialty tier drugs (see H.R. 3418), H9205 [30JY]

———cover supplies associated with insulin injection, home needle removal, decontamination, and disposal devices, and disposal of needles and syringes through a sharps-by-mail or similar program (see S. 1312), S6845 [19JN]

———coverage of intravenous immune globulin for in-home treatments of primary immune deficiency diseases and of certain disposable pumps as durable medical equipment (see H.R. 1765), H4063 [26MR]

———deliver a meaningful drug benefit and lower prescription drug prices (see S. 330), S894 [27JA] (see H.R. 684), H525 [26JA] (see H.R. 2860), H6743 [12JN]

———eliminate coinsurance for screening mammography and colorectal cancer screening tests (see H.R. 2291), H5307 [6MY]

———ensure more appropriate payment amounts for drugs and biologicals by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price (see S. 1221), S6364 [9JN] (see H.R. 1392), H3104 [9MR]

———exempt pharmacies and pharmacists from certain accreditation requirements in the same manner as such exemption applies to certain professionals (see S. 511), S2691 [3MR] (see H.R. 616), H442 [21JA]

———expedite application and qualification process of low-income individuals obtaining subsidized prescription drug coverage (see H.R. 2700), H6263 [4JN]

———improve access of beneficiaries to intravenous immune globulins (IVIG) (see S. 701), S3785 [25MR] (see H.R. 2002), H4580 [21AP]

———improve access to physical medicine and rehabilitation services (see H.R. 1137), H2602 [23FE]

———improve payment methodology for radiopharmaceuticals under hospital outpatient prospective payment system and ensure equitable payment and access to certain radiopharmaceuticals (see H.R. 3917), H11712 [22OC]

———include costs incurred by certain agencies, health centers, or drug assistance programs toward the out-of-pocket threshold of the prescription drug program (see S. 1201), S6255 [8JN] (see H.R. 2777), H6414 [9JN]

———limit prescription drug program premium increases to no more than Social Security cost-of-living adjustment and require Dept. of HHS to negotiate lower prescription drug prices (see H.R. 1832), H4250 [31MR]

———modernize quality improvement organization (QIO) program (see H.R. 2858), H6743 [12JN]

———promote medication therapy management under the part D prescription drug program (see H.R. 3108), H7704 [26JN]

———provide continued coverage for immunosuppressive drugs furnished to beneficiaries that have received a kidney transplant and whose coverage would otherwise expire (see S. 565), S2965 [10MR] (see H.R. 1458), H3399 [12MR]

———provide coverage for the shingles vaccine (see H.R. 1038), H1518 [12FE]

———provide for an update under the physician fee schedule to be fully paid for through medical liability reform, a pathway for biosimilar biological products, and other means (see H.R. 4138), H13352 [19NO]

———provide for consolidated coverage of home infusion drug therapy (see S. 254), S598 [15JA] (see H.R. 574), H380 [15JA]

———reduce coverage gap in prescription drug coverage through savings resulting from negotiation of prescription drug prices (see S. 266), S598 [15JA]

———require use of generic drugs under the prescription drug program when available unless the brand name is determined to be medically necessary (see S. 75), S41 [6JA]

———require wealthy beneficiaries to pay a greater share of their premiums under the prescription drug program (see S. 677), S3657 [24MR]

———standardize marketing requirements under Medicare Advantage and prescription drug programs and provide for State certification prior to waiver of licensure requirements under prescription drug program (see H.R. 3089), H7704 [26JN]

———utilize Value-Based Insurance Design to demonstrate that reducing copayments or coinsurance charged to beneficiaries for selected medications can increase adherence to prescribed medication (see S. 1040), S5501 [14MY]

Medicare/Medicaid: ensure low-income beneficiaries have improved access to prescription drugs (see H.R. 3152), H7946 [9JY]

———establish prescription drug outreach demonstration program for certain eligible individuals with mental disabilities (see H.R. 2390), H5580 [13MY]

———protect and improve prescription drug benefits provided to dual eligible individuals (see S. 1634), S8993 [6AU]

———reduce cost-sharing for certain dual eligible populations under the prescription drug benefit (see S. 534), S2828 [5MR] (see H.R. 1407), H3144 [10MR]

Merida Initiative To Combat Illicit Narcotics and Reduce Organized Crime: submit a report on effects on U.S. border security (see H.R. 3239), H8302 [16JY]

Methadone: increase Federal oversight (see S. 754), S4063 [31MR]

Mexico: support efforts to combat drug trafficking (see S. Res. 72), S2965 [10MR] (see H. Res. 258), H3641 [18MR]

National Alcohol and Drug Addiction Recovery Day: observance (see H. Con. Res. 115), H5061 [30AP]

National Criminal Justice Commission: establish (see S. 714), S3897 [26MR]

National Drug Facts Chat Day: recognize importance (see S. Res. 256), S9186 [9SE] (see H. Res. 728), H9396 [9SE]

National Immunization Awareness Month: support goals and ideals (see H. Res. 709), H9280 [31JY]

National Medicine Abuse Awareness Month: designate (see S. Res. 263), S9326 [14SE]

Native Americans: prevent use of Indian reservations located on U.S. borders to facilitate cross-border drug trafficking (see S. 2893), S13319 [16DE]

New York: designate certain counties as high-intensity drug trafficking areas (see S. 1075), S5614 [19MY] (see H.R. 2494), H5791 [19MY]

NIH: increase funding for medical research with greatest potential for near-term clinical benefit (see H.R. 3475), H9277 [31JY]

Pharmaceuticals: importation of prescription drugs (see S. 80), S41 [6JA] (see S. 525), S2766 [4MR] (see S. 1232), S6452 [10JN] (see H.R. 1298), H2978 [4MR]

———prohibit as indecent the broadcasting of any advertisement for medication for the treatment of erectile dysfunction (see H.R. 2175), H4999 [29AP]

———prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market (see S. 369), S1431 [3FE] (see H.R. 1706), H4025 [25MR]

———provide for disposal of controlled substances by ultimate users and care takers through State take-back disposal programs and prohibit drug label recommendations on disposal by flushing (see S. 1336), S6993 [24JN] (see H.R. 1191), H2834 [25FE]

———provide for take-back disposal of controlled substances in certain instances (see S. 1292), S6804 [18JN] (see H.R. 1359), H3054 [5MR]

———provide tax credit to retirement age individuals, remove barriers to importation, and prohibit certain regulation of Internet sites relative to prescription drugs (see H.R. 163), H34 [6JA]

Protect Your Pharmacy Week: designate (see H. Res. 326), H4524 [2AP]

Public welfare programs: repeal denial to drug felons of eligibility for benefits under the Temporary Assistance for Needy Families Program (see H.R. 3053), H7445 [25JN]

———require States to implement a drug testing program for and recipients of assistance under the Temporary Assistance for Needy Families Program (see S. 97), S42 [6JA]

Safe and Drug-Free Schools and Communities Act: authorize the use of grant funds for gang prevention (see H.R. 1589), H3640 [18MR]

Schools: prohibit Federal education funding for elementary or secondary schools that provide access to emergency postcoital contraception (see H.R. 2458), H5711 [18MY]

Social Security: provide transparency between physicians and manufacturers of drugs, devices, biologicals, or supplies paid for under Medicare, Medicaid, or the State Children's Health Insurance Program (see S. 301), S786 [22JA] (see H.R. 3138), H7945 [9JY]

Tariff: Cetalox (see S. 2045), S10915 [29OC]

———pyrethrum extract (see S. 2337), S10921 [29OC]

———RSD 1235 (see S. 2522), S10959 [30OC] (see S. 2753), S11290 [9NO]

Taxation: allow a deduction for amounts paid for health insurance and prescription drug costs of individuals (see H.R. 198), H35 [6JA]

———deny any deduction for direct-to-consumer advertisements of prescription drugs (see S. 2842), S12618 [7DE] (see S. 2873), S13032 [11DE] (see H.R. 2966), H7084 [19JN]

———deny deduction for advertising and promotional expenses for prescription pharmaceuticals (see S. 1763), S10318 [8OC] (see H.R. 3979), H12197 [2NO]

———prohibit tax deduction for prescription drug advertising (see H.R. 2917), H6971 [17JN]

———treatment of foods for special dietary use, dietary supplements, and medical foods as medical expenses (see H.R. 3263), H8409 [20JY]

Veterans: establish veterans' treatment courts (see S. 902), S4755 [27AP] (see H.R. 2138), H4914 [28AP]

Virgin Islands: authorize shipment of prescription drugs between States and the Virgin Islands (see H.R. 91), H31 [6JA]

Western Hemisphere Drug Policy Commission: establish (see H.R. 2134), H4914 [28AP]

Factsheets

Swine Production, Diseases and Antimicrobial Consumption: National Food Institute, Danish Technical University, H10534 [7OC]

Letters

Ensure Border Patrol agents have access to public lands and remove certain restrictions in order to allow enforcement of immigration and drug smuggling laws: Suzanne Bibby, Eagle Forum (organization), S9802 [24SE]

———T.J. Bonner, American Federation of Government Employees, S9802 [24SE]

Importation of prescription drugs: Margaret A. Hamburg, FDA, S12778 [9DE], S13227 [15DE]

National policy to provide health care and reform insurance procedures: Senator Specter, S7225 [8JY]

Non-therapeutic use of antibiotics on livestock prohibition: Frank M. Aarestrup, National Food Institute, Danish Technical University, H10534 [7OC]

Pharmaceutical Market Access and Drug Safety Act: Senator Reid, S10184 [7OC]

———Susan Eckerly, National Federation of Independent Business, S9714 [23SE]

Phase out nontherapeutic use of antimicrobial drugs in food animals: several health organizations, E2093 [31JY]

Western Hemisphere Drug Policy Commission Act: Representative Berman, Committee on Foreign Affairs (House), H13561, H13562 [8DE]

———Representative Conyers, Committee on the Judiciary (House), H13561 [8DE]

———Representative Waxman, Committee on Energy and Commerce (House), H13562 [8DE]

Lists

Organizations supporting comparative effectiveness research provisions in H.R. 1, American Recovery and Reinvestment Act, H1571 [13FE]

Supporters of S. 914, Cures Acceleration Network establishment, and NIH reauthorization and National Center on Minority Health and Health Disparities elevation to Institute status, S4817 [28AP]

Messages

National Drug Control Strategy: President Bush, S597 [15JA], H370 [15JA]

National Emergency Relative to H1N1 Influenza Pandemic: President Obama, S10733 [26OC], H11755 [26OC]

National Emergency Relative to Narcotics Traffickers in Colombia: President Obama, S10519 [19OC], H11467 [20OC]

Proclamations

Tribute to South Texas Council on Alcohol and Drug Abuse: Representative Cuellar, E2540 [15OC]

Remarks in House

Afghanistan: reduce drug trafficking to eliminate financial support that traffickers provide to terrorist organizations, H13542 [7DE]

Aliviane, Inc.: anniversary, E2938 [10DE]

Andean Trade Promotion and Drug Eradication Act: add Paraguay as a beneficiary country (H.R. 1837), E836 [1AP]

Border Patrol: ensure agents have necessary access to public lands and remove certain restrictions in order to allow optimum enforcement of immigration and drug smuggling laws, H7392 [25JN], H12062 [29OC]

———removal of U.S.-Mexico border drug and people smugglers lookout posts funding, H7193 [24JN]

Caribbean nations: increase efforts under the Third Border Initiative (TBI) to deepen cooperation and collaboration, H6427 [10JN], E1696 [9JY]

Coast Guard: develop strategy to combat illicit flow of narcotics, weapons, bulk cash, and other contraband through use of submersible and semi-submersible vessels, H11719 [23OC]

———provide mission requirement analysis for navigable portions of Rio Grande River international water boundary, H11635 [22OC]

Controlled Substances Act: exclude industrial hemp from the definition of marijuana (H.R. 1866), E860 [2AP]

Crime: concentrate Federal resources aimed at the prosecution of drug offenses on major offenses (H.R. 1466), E656 [12MR]

———impact of illegal immigration on U.S. crime rates, H3416 [16MR]

———target cocaine kingpins and address sentencing disparity between crack and powder cocaine (H.R. 265), E561 [5MR]

Dallas, TX: tribute to Thomas Jefferson High School ``Street Team'' for reducing drug use on campus, E295 [23FE]

Dept. of Agriculture: eligibility of formerly incarcerated persons who were convicted of drug offenses to receive Supplemental Nutrition Assistance Program benefits, H7803 [8JY]

Dept. of Defense: prohibit funding for Drug Interdiction and Counter-Drug Activities Defense account, H9082, H9083 [30JY]

———vaccination of individuals detained at Guantanamo Bay, Cuba, against H1N1 influenza, H12122 [29OC], H12592 [7NO]

Dept. of Education: Safe and Drug-Free Schools and Communities State Grant Program funding, H8755 [24JY]

Dept. of HHS: conduct or support a comprehensive study comparing total health outcomes, including risk of autism, in vaccinated populations with such outcomes in unvaccinated populations (H.R. 3069), E1612 [26JN]

———develop an antimicrobial resistance research strategic plan (H.R. 2400), E1142 [13MY]

———ensure patient choice in pharmacies by regulating pharmacy benefit managers and improving access to prescription drugs for certain individuals (H.R. 4199), E2890 [3DE]

———establish an Agency for Vaccine Safety Evaluation (H.R. 2618), E1240 [21MY]

———improve residential treatment programs for pregnant and parenting women and programs to reduce substance abuse among nonviolent offenders (H.R. 439), H5173 [6MY]

———prohibit funding for needle exchange programs, H8779-H8782 [24JY]

———vaccination of inmates at Texas correctional institutions, E2872 [2DE]

Dept. of Justice: authorize a national program to reduce drug use, crime, and the costs of incarceration (H.R. 4055), E2741 [6NO]

———condition funding for prevention of prosecutorial misconduct on State funding of antidrug task forces, H715 [28JA]

———Edward Byrne Memorial Justice Assistance Grant (Byrne/JAG) Program funding, H1589 [13FE]

———establish the National Parents Corps Program (H.R. 3075), E1837 [17JY]

———prohibit funding for the National Drug Intelligence Center, H6963, H6964 [17JN]

Dept. of State: domestic release of the VOA film ``A Fateful Harvest'', H6493, H6494 [10JN]

———issuance of travel alert for U.S. citizens living and traveling in Mexico due to drug violence, H2909 [3MR], H3319 [11MR], E464 [26FE]

———permit certain foreign government officers or employees to be eligible for the Dept. of State Rewards Program (H.R. 57), E21 [6JA]

Diseases: response to and preparation for potential H1N1 influenza pandemic, H5161-H5166 [5MY], H9554 [16SE], H12592 [7NO], E2872 [2DE]

District of Columbia: tribute to first graduating class of Rivers Correctional Institution Residential Drug Abuse Program, E423 [25FE]

Drug Price Competition and Patent Term Restoration Act: anniversary, E2373 [25SE]

Education: reinstate marijuana possession as grounds for losing a student loan, H9704 [17SE]

EPA: conduct a study on environmental impact of pharmaceuticals and personal care products in water supply and develop recommendations on treatment and prevention, H3353, H3361 [12MR]

———convene a task force to develop recommendations on the proper disposal of unused pharmaceuticals, H3366, H3367 [12MR]

FDA: define term ``first applicant'' for purposes of filing an abbreviated application for a new drug (H.R. 3777), E2487 [8OC]

———funding, H7816, H7817 [8JY]

———improve safety of food, drugs, devices, and cosmetics in the global market (H.R. 759), H3148 [11MR]

———phase out nontherapeutic use of antimicrobial drugs in food animals, H14945 [15DE], E2093 [31JY]

———prohibit diversion of funds to tobacco regulatory efforts from other FDA programs and initiatives, H4413 [2AP]

Federal Food, Drug, and Cosmetic Act: amend relative to distribution of the drug dextromethorphan (H.R. 1259), H4086, H4087 [30MR]

———preserve effectiveness of medically important antibiotics used in treatment of human and animal diseases, H14746 [11DE]

———preserve effectiveness of medically important antibiotics used in treatment of human and animal diseases (H.R. 1549), H8272 [16JY], H10533, H10534 [7OC], E689 [17MR]

———reduce human exposure to mercury through vaccines (H.R. 2617), E1243 [21MY]

Flagstaff, AZ: tribute to Flagstaff Police Dept., H4847 [28AP]

Foreign countries: provide assistance to combat HIV/AIDS, H3725 [23MR], H9479 [14SE], H13445 [2DE]

Forest Hill, LA: tribute to Forest Hill Elementary School first graduating class of the Drug Abuse Resistance Education (D.A.R.E.) program, E1000 [28AP]

Forest Service: drug enforcement activities funding, H7420 [25JN]

Foster, Roy: CNN Heroes honoree, E2928 [10DE]

Government: prohibit from awarding contracts, grants, or other agreements to, providing any other Federal funds to, or engaging in activities that promote certain companies convicted of felonies (H.R. 3679), H10489 [6OC]

Health: allow competition in the biosimilar and interchangeable biological products industry, H12888, H12890, H12891, H12896, H12897, H12899, H12914, H12915 [7NO], E2755 [9NO]

———coverage of mental health and substance abuse prevention and screening, E1862 [21JY]

———impact of economic stimulus legislation on health care, H1136 [10FE], H1219 [11FE], H1592 [13FE]

———include treatment for alcoholism, drug addiction, depression, and mental illness in health care reform legislation, H12049 [29OC]

———purchase, replenish, and expand Federal and State stockpiles of influenza vaccines, antiviral drugs, masks, ventilators and vaccine delivery devices, H5618 [14MY]

Immigration: reform, H5389-H5395 [7MY]

Law enforcement: coordinate efforts to protect U.S. border cities and communities from drug cartels across the border with Mexico, H13270 [19NO]

———coordinate efforts to protect U.S. border cities and communities from drug trafficking, gunrunning, illegal alien smuggling, violence, and kidnapping along and across the border with Mexico, H3996 [25MR], H5134 [5MY]

———increase penalties for trafficking in high potency marijuana (H.R. 2848), E1390 [12JN]

———secure smuggling routes on the U.S.-Mexico border and better prevent the smuggling of narcotics and weapons across the border, H5449 [12MY], H6666 [12JN], H6830 [16JN], H11766 [26OC]

Mackay, Dewey C.: investigation of alleged illegal prescribing of controlled substances, H10493 [6OC], H11085 [7OC], H11149 [8OC]

Marhefka, John: D.A.R.E. (Drug Abuse Resistance Education) (organization) Pennsylvania Officer of the Year award recipient, E2564 [15OC]

McQuarrie, Allen: Pennsylvania Recovery Organization-Achieving Community Together (PRO-ACT) (organization) Joel Hernandez Voice of the Recovery Community Award recipient, E1465 [17JN]

Medicare: allow waiver of copays for biosimilar interchangeable drugs, H12842 [7NO]

———deliver a meaningful drug benefit and lower prescription drug prices (H.R. 684), H7130 [23JN]

———eliminate gap in coverage of prescription drug benefit, H7025 [19JN], H7130 [23JN]

———modernize quality improvement organization (QIO) program (H.R. 2858), H7841 [9JY]

———provide coverage for the shingles vaccine (H.R. 1038), E265 [12FE]

Medicare/Medicaid: establish prescription drug outreach demonstration program for certain eligible individuals with mental disabilities (H.R. 2390), H5552 [13MY]

Mental health: require equity in the provision of mental health and substance-related disorder benefits under group health plans, H8105 [15JY], H8187 [16JY], H8877, H8906 [28JY], H10524 [7OC], E2039 [28JY]

Merida Initiative To Combat Illicit Narcotics and Reduce Organized Crime: assessment of U.S. efforts to prevent the southbound flow of illegal funds into Central America, H6501 [10JN]

———extend membership to Caribbean Community (CARICOM) (organization), E1696 [9JY]

Morristown, NJ: anniversary of the Market Street Mission, E709 [18MR]

National security: improve border security, H1638 [23FE], H2909 [3MR], H3319 [11MR]

Oradell, NJ: tribute to D.A.R.E. (Drug Abuse Resistance Education) (organization) graduates, E1150 [14MY]

Passaic County Council on Alcoholism and Drug Abuse Prevention, Inc.: anniversary, E1211 [20MY]

Pharmaceuticals: lower prescription drug prices, H13272 [19NO]

———prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, H12889 [7NO]

———provide for disposal of controlled substances by ultimate users and care takers through State take-back disposal programs and prohibit drug label recommendations on disposal by flushing (H.R. 1191), E386 [25FE], E489-E492 [26FE]

———provide tax credit to retirement age individuals, remove barriers to importation, and prohibit certain regulation of Internet sites relative to prescription drugs (H.R. 163), E5 [6JA]

Pinal County, AZ: tribute to Pinal County Sheriff's Dept., H5104 [5MY]

Ramsey, NJ: tribute to D.A.R.E. (Drug Abuse Resistance Education) (organization) graduates, E1347 [9JN]

Red Ribbon Week: observance, E2665 [29OC]

RxIMPACT Day: tribute, E1448 [17JN]

Safe and Drug-Free Schools and Communities Act: authorize the use of grant funds for gang prevention (H.R. 1589), E709 [18MR]

Schlichting, Barbara: Somerset County, NJ, Commission on the Status of Women Social Services Award recipient, E636 [11MR]

Sembler, Betty: Florida Women's Hall of Fame inductee, E193 [3FE]

Tibotec Therapeutics (business): tribute to Gender Race and Clinical Experience (GRACE) study, E2426 [1OC], E2597, E2598 [21OC]

U.S. Pharmacopeial Convention (organization): tribute, E2509 [13OC]

Western Hemisphere Drug Policy Commission: establish (H.R. 2134), H13560-H13563, H13568 [8DE], E992 [28AP]

Remarks in Senate

Andean Trade Promotion and Drug Eradication Act: add Paraguay as a beneficiary country (S. 780), S4195, S4196 [1AP]

ATF: authorize additional resources to identify and eliminate illicit sources of firearms smuggled into Mexico for use by drug traffickers (S. 205), S312 [12JA]

Birth control: restore nominal prices of oral contraceptives for family planning clinics that do not receive Federal funding and university-based clinics, S2817 [5MR]

Border Patrol: ensure agents have necessary access to public lands and remove certain restrictions in order to allow optimum enforcement of immigration and drug smuggling laws, S9720 [23SE], S9801-S9803 [24SE]

———provide additional funding to the Depts. of Homeland Security and Justice to strengthen Federal law enforcement efforts along the southwest border, S4031-S4033 [31MR]

Business and industry: cost to produce drugs and devices that provide alternatives to surgery, S11838 [20NO]

Centers for Medicare & Medicaid Services: actuarial report on impact of H.R. 3590, Patient Protection and Affordable Care Act, on Medicare and Medicaid programs, S13088-S13092 [12DE]

Cocaine: adjust penalties for powder cocaine and crack cocaine offenses (S. 1789), S10490-S10493 [15OC]

Colombia: increase prosecution of Revolutionary Armed Forces of Colombia (FARC) members and require the Colombian Government to make reparations to victims, S2823 [5MR]

Controlled Substances Act: prevent abuse of dextromethorphan (S. 1383), S7097 [25JN]

Corp. for National and Community Service: require criminal history check and drug test for controlled substances for certain individuals with access to vulnerable populations, S3826-S3828, S3836 [26MR]

Crime: address criminal and fraudulent monetary transfers using stored value cards and other electronic devices, S5426 [13MY]

———enhance penalties for marketing controlled substances to minors (S. 258), S615 [15JA], S648 [16JA]

Cuba: facilitate export of U.S. agricultural products, remove impediments to export of medical devices and medicines, allow travel by U.S. citizens, and establish an agricultural export promotion program (S. 1089), S5704 [20MY]

Cures Acceleration Network: establish to accelerate research discoveries into life-saving therapies (S. 914), S4813 [28AP]

DEA: enhance ability to combat methamphetamine (S. 256), S614 [15JA], S6315 [8JN]

Dept. of Defense: conduct study on volume and types of antidepressants or antianxiety drugs prescribed to servicemen and the potential relationship between use of such drugs and number of suicide attempts, S7766-S7768 [21JY], S7848 [22JY]

———tribute to U.S. Military HIV Research Program study and testing of AIDS vaccine, S11341 [10NO]

Dept. of HHS: biodefense medical countermeasures development and production funding, S2019, S2020 [9FE]

———revise and expand the 340B Drug Pricing Program to improve provision of discounts on drug purchases for certain safety net providers (S. 1239), S6546 [11JN]

Dept. of Homeland Security: prevent Customs and Border Protection seizure of imported prescription drugs for personal use, S7305, S7306 [9JY]

Dept. of HUD: prohibit housing assistance funds in New Orleans, LA, from benefitting those convicted of selling drugs, domestic violence offenses and members of violent gangs, S9412, S9421 [16SE], S9532, S9533 [17SE]

Dept. of Justice: repeal prohibition on certain Native American communities in Alaska from receiving Federal funds to support local programs, S10212 [7OC]

Dept. of Transportation: establish and maintain national clearinghouse for alcohol and controlled substances testing records of commercial motor vehicle operators (S. 1113), S5728 [20MY]

Diseases: establish programs and activities to increase influenza vaccination rates through the provision of free vaccines (S. 953), S5019 [1MY]

———increase immunization rates (S. 1003), S5287 [7MY]

———preparation for potential H1N1 influenza pandemic, S10805 [28OC]

District of Columbia: prohibit funding for needle exchange programs, S12989 [11DE]

Drug Price Competition and Patent Term Restoration Act: anniversary (S. Res. 287), S9853 [24SE]

Families and domestic relations: allow children in foster care to be placed with their parents in residential family treatment centers that provide safe environments for treating addiction and promoting healthy parenting (S. 1286), S6807 [18JN]

FDA: ensure safety and quality of medical products and enhance authorities (S. 882), S4686 [23AP]

———establish a review process that would recommend solutions for the prevention, diagnosis, and treatment of rare and neglected diseases in the developing world, S8620 [31JY], S8651 [3AU], S10281 [8OC]

———establish a user fee for follow-up reinspections (S. 1477), S7783 [21JY]

———establish standards for the inclusion of risks, benefits, and comparative clinical effectiveness information in drug and device labeling and advertising (S. 1142), S5848 [21MY]

———increase access to lower-cost, generic versions of biologic drugs, S7180 [7JY], S7335 [10JY], S7391 [13JY], S7593-S7595 [16JY], S8186 [28JY]

Federal aid programs: establish a task force to recommend comprehensive legislation addressing expected shortfalls in certain entitlement programs, S5398 [13MY]

Federal Food, Drug, and Cosmetic Act: preserve effectiveness of medically important antibiotics used in treatment of human and animal diseases (S. 619), S3179 [17MR]

———prevent certain delays by pharmaceutical companies in allowing introduction of generic drugs (S. 1778), S10436 [14OC]

———prohibit marketing of authorized generic drugs (S. 501), S2569 [26FE]

Health: impact of economic stimulus legislation on health care, S2197, S2199 [12FE]

———prevent abuse of dehydroepiandrosterone (S. 641), S3553 [19MR]

———provide for the licensure of biosimilar and interchangeable biological products (S. 726), S6793 [18JN]

———understand and comprehensively address oral health problems associated with methamphetamine use (S. 450), S2343 [13FE]

Insurance: improve prescription drug coverage under Medicare and private health insurance (S. 1630), S9027 [6AU]

Law enforcement: coordinate efforts to protect U.S. border cities and communities from drug trafficking, gunrunning, illegal alien smuggling, violence, and kidnapping along and across the border with Mexico, S8074 [24JY]

Medicaid: extend drug rebate program to enrollees of managed care organizations (S. 547), S2911 [9MR]

———pharmacy reimbursement rate for certain generic drugs, S13778 [22DE]

———provide coverage of drugs prescribed for certain NIH research study child participants (S. 406), S2082 [10FE]

Medicare: deliver a meaningful drug benefit and lower prescription drug prices (S. 330), S894 [27JA]

———ensure more appropriate payment amounts for drugs and biologicals by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price (S. 1221), S6383 [9JN]

———improve access of beneficiaries to intravenous immune globulins (IVIG) (S. 701), S3792 [25MR]

———include costs incurred by certain agencies, health centers, or drug assistance programs toward the out-of-pocket threshold of the prescription drug program (S. 1201), S6265 [8JN]

———provide continued coverage for immunosuppressive drugs furnished to beneficiaries that have received a kidney transplant and whose coverage would otherwise expire (S. 565), S2973 [10MR]

———provide for consolidated coverage of home infusion drug therapy (S. 254), S612 [15JA]

———reduce coverage gap in prescription drug coverage through savings resulting from medical malpractice tort reform, S13592 [20DE]

———remove prompt payment discount on prescription drugs, S1674 [5FE]

———require use of generic drugs under the prescription drug program when available unless the brand name is determined to be medically necessary (S. 75), S74 [6JA]

———require wealthy beneficiaries to pay a greater share of their premiums under the prescription drug program, S4247, S4248 [2AP]

Medicare/Medicaid: protect and improve prescription drug benefits provided to dual eligible individuals (S. 1634), S9029 [6AU]

Methadone: increase Federal oversight (S. 754), S4080 [31MR]

National Criminal Justice Commission: establish (S. 714), S3900-S3904 [26MR], S11013 [3NO], S13185 [14DE]

National Drug Facts Chat Day: recognize importance (S. Res. 256), S9188 [9SE]

National Guard: counterdrug programs funding, S9972 [30SE]

Pharmaceuticals: importation of prescription drugs, S5927-S5929 [2JN], S6171 [4JN], S6233, S6234, S6246, S6247 [8JN], S6415 [10JN], S7299 [9JY], S10182-S10188, S10192 [7OC], S10404 [14OC], S10687-S10689 [22OC], S10804 [28OC], S10955 [30OC], S11876 [20NO], S12546, S12547 [6DE], S12686-S12688 [8DE], S12751-S12759, S12765, S12770-S12774, S12776-S12780, S12784-S12789, S12792 [9DE], S12870-S12872 [10DE], S12978 [11DE], S13082, S13083 [12DE], S13167, S13168, S13177 [14DE], S13212, S13216, S13219, S13221-S13235, S13238, S13239 [15DE], S13622 [20DE]

———importation of prescription drugs (S. 525), S2780 [5MR]

———importation of prescription drugs (S. 1232), S6478 [10JN], S6481 [11JN], S6866 [22JN], S8216 [29JY], S9713-S9715 [23SE], S9898 [29SE]

———lower prescription drug prices, S11953 [21NO], S13165, S13166 [14DE]

———prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, S13240 [15DE]

———prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market (S. 369), S1433 [3FE]

———provide for take-back disposal of controlled substances in certain instances (S. 1292), S6810 [18JN]

Public welfare programs: implement drug testing programs for recipients of Temporary Assistance for Needy Families funds, S4288 [2AP]

Social Security: provide transparency between physicians and manufacturers of drugs, devices, biologicals, or supplies paid for under Medicare, Medicaid, or the State Children's Health Insurance Program (S. 301), S787-S789 [22JA], S9729 [23SE]

States: permit use of tax credits to negotiate health care premium rates, S13862 [23DE]

Taxation: deny deduction for advertising and promotional expenses for prescription pharmaceuticals (S. 1763), S10320 [8OC]

Warren County Prevention Partnership (organization): tribute to participation in the Presidential inaugural parade, S1055 [29JA]

Reports filed

Combat Methamphetamine Enhancement Act: Committee on the Judiciary (Senate) (S. 256), S3609 [23MR]

Dextromethorphan Distribution Act: Committee on Energy and Commerce (House) (H.R. 1259) (H. Rept. 111-49), H3833 [24MR]

Preserve Access to Affordable Generics Act: Committee on the Judiciary (Senate) (S. 369), S10486 [15OC]

Summaries

American Recovery and Reinvestment Act (H.R. 1): Comparative Effectiveness Research Provisions, H1570 [13FE]

Testimonies

Sentencing Commission Responsibilities: Robert Pratt, S13186-S13188 [14DE]

Texts of

H.R. 1259, Dextromethorphan Distribution Act, H4086 [30MR]

H.R. 2134, Western Hemisphere Drug Policy Commission Act, H13560 [8DE]

S. 75, Generics First Act, S74 [6JA]

S. 205, Southwest Border Violence Reduction Act, S312 [12JA]

S. 254, Medicare Home Infusion Therapy Coverage Act, S613 [15JA]

S. 256, Combat Methamphetamine Enhancement Act, S615 [15JA], S6315 [8JN]

S. 258, Saving Kids From Dangerous Drugs Act, S616 [15JA]

S. 330, Medicare Prescription Drug Savings and Choice Act, S895 [27JA]

S. 369, Preserve Access to Affordable Generics Act, S1433 [3FE]

S. 450, Meth Mouth Prevention and Community Recovery Act, S2343-S2345 [13FE]

S. 547, Drug Rebate Equalization Act, S2912 [9MR]

S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act, S2974 [10MR]

S. 914, Cures Acceleration Network establishment to accelerate research discoveries into life-saving therapies, and NIH reauthorization and National Center on Minority Health and Health Disparities elevation to Institute status, S4815-S4817 [28AP]

S. 1003, Immunization Improvement Act, S5288-S5290 [7MY]

S. 1142, Informed Health Care Decision Making Act, S5849 [21MY]

S. 1201, Helping Fill the Medicare Rx Gap Act, S6265 [8JN]

S. 1221, ensure more appropriate Medicare payment amounts for drugs and biologicals by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price, S6383 [9JN]

S. 1239, 340B Program Improvement and Integrity Act, S6546-S6548 [11JN]

S. 1383, Dextromethorphan Abuse Reduction Act, S7098 [25JN]

S. 1630, Affordable Access to Prescription Medications Act, S9027-S9029 [6AU]

S. 1634, Medicare Prescription Drug Coverage Improvement Act, S9030-S9038 [6AU]

S. Res. 72, support efforts to combat drug trafficking in Mexico, S2979 [10MR]

S. Res. 256, recognize importance of National Drug Facts Chat Day, S9188 [9SE]

S. Res. 263, National Medicine Abuse Awareness Month, S9330 [14SE]

S. Res. 287, Drug Price Competition and Patent Term Restoration Act anniversary, S9853 [24SE]